# Cyclin-dependent kinase inhibitor payloads

Source: https://onco.cc/terms/cdk-inhibitor-payloads/  
OnCo record `cdk-inhibitor-payloads` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

These payloads block enzymes that help cells divide or read genes. An antibody may help deliver them to cancer cells that depend on those processes.

## Summary

A cetuximab conjugate carrying SNS-032 was tested in EGFR-expressing triple-negative breast cancer cells, spheroids and xenograft models. SNS-032 inhibits CDK2, CDK7 and CDK9; it should not be described as a selective CDK9 payload. The study supports preclinical cell-cycle-directed delivery. A CDK inhibitor payload is also different from a degrader payload that removes a CDK protein.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: CDK inhibitor payloads; CDK2/7/9 inhibitor conjugates; SNS-032 payload; CDK9 inhibitor payloads

## Sources

- Cetuximab-SNS-032 in breast cancer models (2024): https://doi.org/10.1158/1078-0432.CCR-23-3110

## Connected records

- terms: [Next-generation antibody-conjugate payloads](https://onco.cc/terms/next-generation-adc-payloads/), [Payload (ADC)](https://onco.cc/terms/payload/), [Transcription-inhibitor payloads](https://onco.cc/terms/transcription-inhibitor-payloads/)
- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)

---
JSON: https://onco.cc/api/v1/entities/cdk-inhibitor-payloads.json